Alan L Parker

26PUBLICATIONS
66CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsTumour immunologyMolecular targetsGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Apr 28, 2026
Identification of a novel fiber shaft structural motif and overexpression of key transcripts elucidated in human adenovirus D 10.

|May 13, 2025
GP73: the key to unlocking immunotherapies efficacy in solid tumors?

Rebecca J Bayliss, Alan L Parker

|Oct 05, 2024
The αvβ6 integrin specific virotherapy, Ad5NULL-A20.FCU1, selectively delivers potent "in-tumour" chemotherapy to pancreatic ductal adenocarcinoma.

Luned M Badder, James A Davies, Valerie S Meniel

|Jun 27, 2024
The Immune System-A Double-Edged Sword for Adenovirus-Based Therapies.

Rebecca Wallace, Carly M Bliss, Alan L Parker

|Jun 05, 2024
Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines.

Joshua Gardner, Simon Timothy Abrams, Cheng-Hock Toh

|Aug 26, 2023
Oncolytic Viruses and Immune Checkpoint Inhibitors: The "Hot" New Power Couple.

Charlotte Lovatt, Alan L Parker

Pageof 5

Frequent Collaborators

4 joint publications

Alexander T Baker

3 joint publications

Charlotte Lovatt

2 joint publications

Lynda Coughlan

2 joint publications

Andrew K Sewell